Cue Health receives EUA from FDA for mpox virus molecular test

Cue Health announced it has received Emergency Use Authorization, or EUA, from the FDA for its molecular test to detect the mpox virus. This nucleic acid amplification test is run on a Cue Reader, can be performed at any CLIA-waived facility and delivers results in 25 minutes, significantly expanding access to fast and accurate testing for patients.